These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 14587293

  • 1. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H, Brew K.
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [Abstract] [Full Text] [Related]

  • 2. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.
    Hosseini A, Kumar S, Hedin K, Raeeszadeh-Sarmazdeh M.
    Protein Sci; 2023 Dec; 32(12):e4795. PubMed ID: 37807423
    [Abstract] [Full Text] [Related]

  • 3. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
    Wei S, Xie Z, Filenova E, Brew K.
    Biochemistry; 2003 Oct 28; 42(42):12200-7. PubMed ID: 14567681
    [Abstract] [Full Text] [Related]

  • 4. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH, Rapti M, Knaüper V, Murphy G.
    J Biol Chem; 2004 Apr 23; 279(17):17562-9. PubMed ID: 14734567
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
    Batra J, Soares AS, Mehner C, Radisky ES.
    PLoS One; 2013 Apr 23; 8(9):e75836. PubMed ID: 24073280
    [Abstract] [Full Text] [Related]

  • 6. Engineering of selective TIMPs.
    Nagase H, Meng Q, Malinovskii V, Huang W, Chung L, Bode W, Maskos K, Brew K.
    Ann N Y Acad Sci; 1999 Jun 30; 878():1-11. PubMed ID: 10415716
    [Abstract] [Full Text] [Related]

  • 7. MMP-TIMP interaction depends on residue 2 in TIMP-4.
    Stratmann B, Farr M, Tschesche H.
    FEBS Lett; 2001 Nov 02; 507(3):285-7. PubMed ID: 11696356
    [Abstract] [Full Text] [Related]

  • 8. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L, Tanaka M, Wait R, Shi YE, Brew K, Nagase H.
    Biochemistry; 2002 Dec 17; 41(50):15025-35. PubMed ID: 12475252
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y, Koda M, Murawaki Y.
    Res Commun Mol Pathol Pharmacol; 2004 Dec 17; 115-116():143-50. PubMed ID: 17564313
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
    Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH.
    Brain Res Mol Brain Res; 2002 Apr 30; 100(1-2):103-17. PubMed ID: 12008026
    [Abstract] [Full Text] [Related]

  • 11. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
    Remacle AG, Shiryaev SA, Radichev IA, Rozanov DV, Stec B, Strongin AY.
    J Biol Chem; 2011 Jun 10; 286(23):21002-12. PubMed ID: 21518756
    [Abstract] [Full Text] [Related]

  • 12. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2005 Apr 22; 280(16):15967-75. PubMed ID: 15713681
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
    Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W.
    Nature; 1997 Sep 04; 389(6646):77-81. PubMed ID: 9288970
    [Abstract] [Full Text] [Related]

  • 14. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2003 Oct 10; 278(41):40224-30. PubMed ID: 12869573
    [Abstract] [Full Text] [Related]

  • 15. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K.
    Protein Sci; 2007 Sep 10; 16(9):1905-13. PubMed ID: 17660250
    [Abstract] [Full Text] [Related]

  • 16. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
    Brew K, Nagase H.
    Biochim Biophys Acta; 2010 Jan 10; 1803(1):55-71. PubMed ID: 20080133
    [Abstract] [Full Text] [Related]

  • 17. Insights into MMP-TIMP interactions.
    Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K.
    Ann N Y Acad Sci; 1999 Jun 30; 878():73-91. PubMed ID: 10415721
    [Abstract] [Full Text] [Related]

  • 18. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W, Meng Q, Suzuki K, Nagase H, Brew K.
    J Biol Chem; 1997 Aug 29; 272(35):22086-91. PubMed ID: 9268350
    [Abstract] [Full Text] [Related]

  • 19. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F, Munaut C, Frankenne F, Perrier D'Hauterive S, Béliard A, Fridman V, Nervo P, Colige A, Foidart JM.
    Biol Reprod; 2003 Sep 29; 69(3):976-84. PubMed ID: 12773401
    [Abstract] [Full Text] [Related]

  • 20. Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.
    Nagase H, Brew K.
    Arthritis Res; 2002 Sep 29; 4 Suppl 3(Suppl 3):S51-61. PubMed ID: 12110123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.